<em>NDRG</em>2通过抑制β-catenin表达和入核调控乳腺癌细胞增殖

周晓雷; 朱重悦; 张世光

doi:10.19401/j.cnki.1007-3639.2016.12.004

您当前的位置：

首页 >

文章列表页 >

NDRG2通过抑制β-catenin表达和入核调控乳腺癌细胞增殖

更新时间：2025-12-31

- NDRG2通过抑制β-catenin表达和入核调控乳腺癌细胞增殖
- NDRG2 inhibits the proliferation of breast cancer cells via regulating β-catenin expression and nuclear translocation
- 中国癌症杂志 2016年26卷第12期页码：981-988
- 作者机构：
  
  河北科技大学生物实验中心,河北,石家庄,050018
- 作者简介：
- 基金信息：
  
  河北省高等学校科学研究项目(QN2016020);2015年度河北科技大学五大平台开放基金课题;河北科技大学博士科研启动基金课题。
- DOI：10.19401/j.cnki.1007-3639.2016.12.004
  中图分类号：
- 网络出版：2017-01-23，
  
  纸质出版：2016-01-23
- 稿件说明：
移动端阅览
周晓雷,朱重悦,张世光,等.

周晓雷, 朱重悦, 张世光. NDRG2 inhibits the proliferation of breast cancer cells via regulating β-catenin expression and nuclear translocation[J]. China Oncology, 2016, 26(12): 981-988.
周晓雷,朱重悦,张世光,等. DOI： 10.19401/j.cnki.1007-3639.2016.12.004.

周晓雷, 朱重悦, 张世光. NDRG2 inhibits the proliferation of breast cancer cells via regulating β-catenin expression and nuclear translocation[J]. China Oncology, 2016, 26(12): 981-988. DOI： 10.19401/j.cnki.1007-3639.2016.12.004.

摘要

背景与目的：乳腺癌是女性发病率最高的恶性肿瘤之一，肿瘤细胞的恶性增殖是造成患者死亡的重要原因。本研究利用具有相同遗传背景但不同增殖能力的乳腺癌细胞模型，研究N-myc下游调节基因2(N-myc downstream regulated gene 2，NDRG2)调控乳腺癌细胞增殖的作用及分子机制。方法：通过蛋白［质］印迹法(Western blot)检测MCF-7/LM-MCF-7细胞中NDRG2蛋白表达水平；构建NDRG2真核表达载体及siRNA干扰片段，通过转染上调或沉默NDRG2表达，流式细胞实验检测细胞增殖能力，Western blot检测β-连环蛋白(β-catenin)表达，免疫荧光染色检测β-catenin细胞定位；共转染MCF-7细胞NDRG2 siRNA和pCMV-Tcfδ，流式细胞实验检测细胞增殖能力。结果：NDRG2的蛋白表达水平同乳腺癌细胞增殖能力负相关；在增殖的LMMCF-7细胞中上调NDRG2表达，细胞增殖指数(proliferation index，PI)由47.18%下降至31.78%(P0.001)；在低增殖的MCF-7细胞中沉默NDRG2表达，PI由32.00%上升至52.59%(P0.001)；Western blot及免疫荧光结果显示，NDRG2可抑制β-catenin表达，并抑制其聚集入核；流式细胞检测结果显示，共转染siRNA和pCMV-Tcfδ的MCF-7细胞增殖能力未增强，进一步说明NDRG2是通过抑制β-catenin的转录调节作用抑制肿瘤细胞增殖。结论：在乳腺癌细胞中，NDRG2的表达水平下调，导致β-catenin聚集入核，并激活下游靶基因，促进乳腺癌细胞增殖。此分子机制对阐明乳腺癌细胞增殖调控机制具有重要意义。

Abstract

Background and purpose: Breast cancer is one of the most common malignant diseases in women and its malignant proliferation is the major cause of death. To investigate the effects of N-myc downstream regulated gene 2 (NDRG2) on proliferation of breast cancer cells by using two parallel cell lines (MCF-7 and LM-MCF-7) with different metastatic abilities. Methods: The expression level of NDRG2 in breast cancer cells was detected by Western blot. The effects of overexpressing (or down-regulating) NDRG2 on proliferation of breast cancer cells were investigated by flow cytometry. The expression and location of β-catenin were detected by Western blot and immunofluorescence respectively. NDRG2 blocking the transcription activity of β-catenin was investigated via co-transfecting MCF-7 cells with NDRG2 siRNA and pCMV-Tcfδ (lacking the portion responsible for the protein binding to DNA). Results: The expression level of NDRG2 was negatively related to the proliferation ability of breast cancer cells. Over-expressing NDRG2 (or down-regulating) via transfecting LM-MCF-7 (or MCF-7) cells with pCMV-NDRG2 (or NDRG2 siRNA) could inhibit (or promote) cell proliferation. Interestingly

the results of Western blot

immunofluorescence and flow cytometry revealed that down-regulation of NDRG2 resulted from the down-regulation of β-catenin and blocking its nuclear translocation

which led to losing control of the proliferation of breast cancer cells. Conclusion: NDRG2 inhibit the proliferation of breast cancer cells via down-regulating the expression of β-catenin and blocking its nuclear translocation

which is significant for exploring the molecular mechanism of proliferation of breast cancer cells.

关键词

Keywords

references

浏览量

2285

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

TBRG4在肺腺癌中的作用及其机制研究

乳腺肿瘤整形与乳房重建专家共识（2018年版）

干扰FBI-1表达对人乳腺癌细胞增殖的影响及其作用机制研究

化学诱导性大鼠肝癌形成过程中β-catenin表达的实验研究

干细胞标志物SOX-2、β-catenin表达与胃癌术后复发转移关系

NDRG2通过抑制β-catenin表达和入核调控乳腺癌细胞增殖

NDRG2 inhibits the proliferation of breast cancer cells via regulating β-catenin expression and nuclear translocation

DOI：10.19401/j.cnki.1007-3639.2016.12.004

摘要

Abstract

关键词

Keywords

references